ConductScience.org, home

Trial · NCT00726232

Adverse events1,896

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersPV: Ruxolitinib 10 mg BID1619
otherAnaemiaBlood and lymphatic system disordersPV: Ruxolitinib 25 mg BID68
otherAnaemiaBlood and lymphatic system disordersPV: Ruxolitinib 50 mg QD37
otherAnaemiaBlood and lymphatic system disordersET: Ruxolitinib 10 mg BID58
otherAnaemiaBlood and lymphatic system disordersET: Ruxolitinib 25 mg BID1922
otherAnaemiaBlood and lymphatic system disordersET: Ruxolitinib 50 mg QD69
otherAnaemiaBlood and lymphatic system disordersPV: Ruxolitinib All Doses Combined- Expansion Phase2734
otherAnaemiaBlood and lymphatic system disordersET: Ruxolitinib All Doses Combined-expansion Phase3239
otherThrombocytopeniaBlood and lymphatic system disordersPV: Ruxolitinib 10 mg BID619
otherThrombocytopeniaBlood and lymphatic system disordersPV: Ruxolitinib 25 mg BID48
otherThrombocytopeniaBlood and lymphatic system disordersPV: Ruxolitinib 50 mg QD17
otherThrombocytopeniaBlood and lymphatic system disordersET: Ruxolitinib 10 mg BID08
otherThrombocytopeniaBlood and lymphatic system disordersET: Ruxolitinib 25 mg BID022
otherThrombocytopeniaBlood and lymphatic system disordersET: Ruxolitinib 50 mg QD09
otherThrombocytopeniaBlood and lymphatic system disordersPV: Ruxolitinib All Doses Combined- Expansion Phase1734
otherThrombocytopeniaBlood and lymphatic system disordersET: Ruxolitinib All Doses Combined-expansion Phase039
otherLeukopeniaBlood and lymphatic system disordersPV: Ruxolitinib 10 mg BID419
otherLeukopeniaBlood and lymphatic system disordersPV: Ruxolitinib 25 mg BID18
otherLeukopeniaBlood and lymphatic system disordersPV: Ruxolitinib 50 mg QD07
otherLeukopeniaBlood and lymphatic system disordersET: Ruxolitinib 10 mg BID08

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00726232/events